ACE2 and COVID-19: Three genes encoding the angiotensin-converting enzyme 2 (ACE2), the human leukocyte antigen (HLA), Toll-like receptor (TLR), and complement pathway are suggested to be the primary determinant of COVID-19 outcomes6.